{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:08:49Z","timestamp":1783001329034,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined how often genetic clinicians correctly identify psychosocial difficulties in women at high breast cancer risk and explored effects of this assessment and the genetic test result on counselees\u2019 distress. A prospective observational study of counselee\u2013clinician dyads was performed in three French, German and Spanish genetic clinics, involving 709 counselees (participation rate, 83.4%) and 31 clinicians (participation rate, 100%). Counselee\u2013clinician agreement in perceived psychosocial difficulties was measured after the pre-test genetic consultation. Multivariate mixed linear models accounting for clinicians were tested. Predicted distress levels were assessed after the pre- (T1) and post-test result disclosure consultations (T2). Depending on the difficulty domain, clinicians adequately assessed the presence or absence of difficulties in 51% (\u201cfamilial issues\u201d) to 59% (\u201cemotions\u201d) of counselees. When counselees\u2019 and clinicians\u2019 perceptions disagreed, difficulties were generally underestimated by clinicians. Counselees\u2019 distress levels remained stable from T1 to T2, irrespective of clinicians\u2019 appraisal adequacy, and the genetic test result disclosure. Psychological referral need were found in 20\u201342% of counselees, more frequently observed for difficulties in the \u201cemotions\u201d domain. Our findings suggest that the genetic test result is a suboptimal indicator for psychological referral. Instead, clinicians should focus on emotions expressed by counselees to appraise their needs for psychological support.<\/jats:p>","DOI":"10.1038\/s41431-022-01096-9","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T02:02:38Z","timestamp":1649642558000},"page":"1067-1075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-5371","authenticated-orcid":false,"given":"Anne","family":"Br\u00e9dart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-8411","authenticated-orcid":false,"given":"Jean-Luc","family":"Kop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9985-8397","authenticated-orcid":false,"given":"Anja","family":"T\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-073X","authenticated-orcid":false,"given":"Antoine","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-2009","authenticated-orcid":false,"given":"Peter","family":"Devilee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Schmutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-8309","authenticated-orcid":false,"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Dolbeault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira C, Luccarini C, Wahlstr\u00f6m KA, et al. Breast cancer risk genes\u2014association analysis in more than 113,000 women. N Engl J Med. 2021;384:428\u201339.","journal-title":"N Engl J Med"},{"key":"1096_CR2","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/pon.4686","volume":"27","author":"I Esteban","year":"2018","unstructured":"Esteban I, Vilaro M, Adrover E, Angulo A, Carrasco E, Gadea N, et al. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018;27:1530\u20137.","journal-title":"Psychooncology"},{"key":"1096_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s10897-014-9695-6","volume":"23","author":"S Hiraki","year":"2014","unstructured":"Hiraki S, Rinella ES, Schnabel F, Oratz R, Ostrer H. Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns. 2014;23:604\u201317.","journal-title":"J Genet Couns"},{"key":"1096_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/cncr.33357","volume":"127","author":"JO Culver","year":"2021","unstructured":"Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, et al. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021;127:1275\u201385.","journal-title":"Cancer"},{"key":"1096_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/pon.3485","volume":"23","author":"W Eijzenga","year":"2014","unstructured":"Eijzenga W, Bleiker EM, Hahn DE, Kluijt I, Sidharta GN, Gundy C, et al. Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psychooncology. 2014;23:862\u20139.","journal-title":"Psychooncology"},{"key":"1096_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41431-018-0257-5","volume":"27","author":"T Yanes","year":"2019","unstructured":"Yanes T, Willis AM, Meiser B, Tucker KM, Best M. Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review. Eur J Hum Genet. 2019;27:28\u201335.","journal-title":"Eur J Hum Genet"},{"key":"1096_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/pon.933","volume":"14","author":"B Meiser","year":"2005","unstructured":"Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology. 2005;14:1060\u201374.","journal-title":"Psychooncology"},{"key":"1096_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12160-008-9060-9","volume":"36","author":"TM Beran","year":"2008","unstructured":"Beran TM, Stanton AL, Kwan L, Straatsma BR, Burgess BL. The trajectory of psychological impact in BRCA1\/2 genetic testing: does time heal? Ann Behav Med. 2008;36:107\u201316.","journal-title":"Ann Behav Med"},{"key":"1096_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bjc.2012.599","volume":"108","author":"A Bredart","year":"2013","unstructured":"Bredart A, Kop JL, Depauw A, Caron O, Sultan S, Leblond D, et al. Short-term psychological impact of the BRCA1\/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer. Br J Cancer. 2013;108:1012\u201320.","journal-title":"Br J Cancer"},{"key":"1096_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41431-018-0310-4","volume":"27","author":"C Jacobs","year":"2019","unstructured":"Jacobs C, Patch C, Michie S. Communication about genetic testing with breast and ovarian cancer patients: a scoping review. Eur J Hum Genet. 2019;27:511\u201324.","journal-title":"Eur J Hum Genet."},{"key":"1096_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/pon.3920","volume":"24","author":"P Butow","year":"2015","unstructured":"Butow P, Price MA, Shaw JM, Turner J, Clayton JM, Grimison P, et al. Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines. Psychooncology. 2015;24:987\u20131001.","journal-title":"Psychooncology"},{"key":"1096_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10897-008-9173-0","volume":"17","author":"B Meiser","year":"2008","unstructured":"Meiser B, Irle J, Lobb E, Barlow-Stewart K. Assessment of the content and process of genetic counseling: a critical review of empirical studies. J Genet Couns. 2008;17:434\u201351.","journal-title":"J Genet Couns"},{"key":"1096_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/pon.3435","volume":"23","author":"C Maheu","year":"2014","unstructured":"Maheu C, Bouhnik AD, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, et al. Which factors predict proposal and uptake of psychological counselling after BRCA1\/2 test result disclosure? Psychooncology. 2014;23:420\u20137.","journal-title":"Psychooncology"},{"key":"1096_CR14","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1200\/JCO.2014.55.4576","volume":"32","author":"W Eijzenga","year":"2014","unstructured":"Eijzenga W, Aaronson NK, Hahn DE, Sidharta GN, van der Kolk LE, Velthuizen ME, et al. Effect of routine assessment of specific psychosocial problems on personalized communication, counselors\u2019 awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. J Clin Oncol. 2014;32:2998\u20133004.","journal-title":"J Clin Oncol"},{"key":"1096_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.pec.2021.03.025","volume":"104","author":"B Biesecker","year":"2021","unstructured":"Biesecker B, Lewis MA. Advancing genomic translation: Investigations in communication. A special series on communication research in the context of genomic medicine. Patient Educ Couns. 2021;104:933\u20134.","journal-title":"Patient Educ Couns"},{"key":"1096_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pec.2013.05.004","volume":"92","author":"RL Street Jr","year":"2013","unstructured":"Street RL Jr. How clinician-patient communication contributes to health improvement: modeling pathways from talk to outcome. Patient Educ Couns. 2013;92:286\u201391.","journal-title":"Patient Educ Couns"},{"key":"1096_CR17","doi-asserted-by":"publisher","first-page":"e029926","DOI":"10.1136\/bmjopen-2019-029926","volume":"9","author":"A Bredart","year":"2019","unstructured":"Bredart A, Kop JL, Dick J, Cano A, De Pauw A, Anota A, et al. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study. BMJ Open. 2019;9:e029926.","journal-title":"BMJ Open"},{"key":"1096_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","volume":"105","author":"J Moretta","year":"2018","unstructured":"Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]. Bull Cancer. 2018;105:907\u201317.","journal-title":"Bull Cancer"},{"key":"1096_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort G, Chirivella I, Morales R, Ales-Martinez JE, Andres R, Balmana J, et al. SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol. 2015;17:956\u201361.","journal-title":"Clin Transl Oncol"},{"key":"1096_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","volume":"175","author":"U Bick","year":"2019","unstructured":"Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, et al. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat. 2019;175:217\u201328.","journal-title":"Breast Cancer Res Treat"},{"key":"1096_CR21","doi-asserted-by":"publisher","first-page":"e13173","DOI":"10.1111\/ecc.13173","volume":"29","author":"A Bredart","year":"2020","unstructured":"Bredart A, Anota A, Dick J, Cano A, De Pauw A, Kop JL, et al. The \u201cPsychosocial Aspects in Hereditary Cancer\u201d questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions. Eur J Cancer Care. 2020;29:e13173.","journal-title":"Eur J Cancer Care"},{"key":"1096_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1192\/bjp.156.1.79","volume":"156","author":"D Razavi","year":"1990","unstructured":"Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990;156:79\u201383.","journal-title":"Br J Psychiatry"},{"key":"1096_CR23","unstructured":"Herrmann-Lingen CBU, Snaith RP. HADS-D: Hospital Anxiety and Depression Scale\u2014German; Manual. Bern: Hans Huber; 2011."},{"key":"1096_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0163-8343(03)00043-4","volume":"25","author":"MJ Herrero","year":"2003","unstructured":"Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hospital Psychiatry. 2003;25:277\u201383.","journal-title":"Gen Hospital Psychiatry"},{"key":"1096_CR25","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360\u20133.","journal-title":"Fam Med"},{"key":"1096_CR26","first-page":"461","volume":"6","author":"S Gideon","year":"1978","unstructured":"Gideon S. Estimating the dimension of a model. Ann Stat. 1978;6:461\u20134.","journal-title":"Ann Stat"},{"key":"1096_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/sj.bjc.6604952","volume":"100","author":"S Singer","year":"2009","unstructured":"Singer S, Kuhnt S, G\u00f6tze H, Hauss J, Hinz A, Liebm A, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100:908\u201312.","journal-title":"Br J Cancer"},{"key":"1096_CR28","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1640::AID-CNCR21>3.0.CO;2-#","volume":"83","author":"S Newell","year":"1998","unstructured":"Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do medical oncologists\u2019 perceptions reflect their patients\u2019 reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer. 1998;83:1640\u201351.","journal-title":"Cancer"},{"key":"1096_CR29","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2011.35.9281","volume":"29","author":"DW Shin","year":"2011","unstructured":"Shin DW, Kim SY, Cho J, Sanson-Fisher RW, Guallar E, Chai GY, et al. Discordance in perceived needs between patients and physicians in oncology practice: a nationwide survey in Korea. J Clin Oncol. 2011;29:4424\u20139.","journal-title":"J Clin Oncol"},{"key":"1096_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1023\/B:JOGC.0000044201.73103.4f","volume":"13","author":"PN Butow","year":"2004","unstructured":"Butow PN, Lobb EA. Analyzing the process and content of genetic counseling in familial breast cancer consultations. J Genet Couns. 2004;13:403\u201324.","journal-title":"J Genet Couns"},{"key":"1096_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-015-0063-6","volume":"3","author":"L Gouveia","year":"2015","unstructured":"Gouveia L, Lelorain S, Bredart A, Dolbeault S, Bonnaud-Antignac A, Cousson-Gelie F, et al. Oncologists\u2019 perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates. BMC Psychol. 2015;3:6.","journal-title":"BMC Psychol"},{"key":"1096_CR32","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1200\/JCO.1998.16.4.1594","volume":"16","author":"SD Passik","year":"1998","unstructured":"Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald D, Edgerton S. Oncologists\u2019 recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594\u20131600.","journal-title":"J Clin Oncol"},{"key":"1096_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pec.2011.04.017","volume":"86","author":"J Vos","year":"2012","unstructured":"Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, et al. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees\u2019 perception matters, but the actual BRCA1\/2 result does not. Patient Educ Couns. 2012;86:239\u201351.","journal-title":"Patient Educ Couns"},{"key":"1096_CR34","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1007\/s00520-019-04918-7","volume":"27","author":"L Lombardi","year":"2019","unstructured":"Lombardi L, Bramanti SM, Babore A, Stuppia L, Trumello C, Antonucci I, et al. Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature. Support Care Cancer. 2019;27:3647\u201356.","journal-title":"Support Care Cancer"},{"key":"1096_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1034\/j.1399-0004.2001.600501.x","volume":"60","author":"BB Biesecker","year":"2001","unstructured":"Biesecker BB. Goals of genetic counseling. Clin Genet. 2001;60:323\u201330.","journal-title":"Clin Genet"},{"key":"1096_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jgc4.1363","volume":"30","author":"BB Biesecker","year":"2021","unstructured":"Biesecker BB, Lillie SE, Amendola LM, Donohue KE, East KM, Foreman AKM, et al. A review and definition of \u2018usual care\u2019 in genetic counseling trials to standardize use in research. J Genet Couns. 2021;30:42\u201350.","journal-title":"J Genet Couns"},{"key":"1096_CR37","doi-asserted-by":"crossref","first-page":"147997312093329","DOI":"10.1177\/1479973120933292","volume":"17","author":"SC Wynne","year":"2020","unstructured":"Wynne SC, Patel S, Barker RE, Jones SE, Walsh JA, Kon SS, et al. Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chronic Respiratory Dis. 2020;17:1479973120933292.","journal-title":"Chronic Respiratory Dis"},{"key":"1096_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1054\/bjoc.2000.1545","volume":"84","author":"W S\u00f6llner","year":"2001","unstructured":"S\u00f6llner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84:179\u201385.","journal-title":"Br J Cancer"},{"key":"1096_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41431-020-00799-1","volume":"29","author":"NM Medendorp","year":"2021","unstructured":"Medendorp NM, Hillen MA, Visser LNC, Aalfs CM, Duijkers FAM, van Engelen K, et al. A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes? Eur J Hum Genet. 2021;29:789\u201399.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01096-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T23:04:36Z","timestamp":1662073476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01096-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01096-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DSL declares the following conflict of interest: AstraZeneca is funding the French COVAR study coordinated by the Institut Curie and aiming to the classification of <i>BRCA1\/2<\/i> Variants of Unknown Significance. The Department of Genetics of the Institut Curie is performing genotyping (PRS) of MammoRisk\u00ae, Predilife. DSL and the Institut Curie have received honorarium for her participation in education meetings organized by AstraZeneca or Tesaro\u00ae. RS declares the following conflict of interest: grants or contracts received from AstraZeneca, Amgen. Payment or honoraria received from AstraZeneca, JanssenCilag. Participation on an Advisory Board for AstraZeneca; MSD, GSK, Clovis Oncology. PD reports grants from EU Horizon 2020 program during the conduct of the study. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved in France by the Comit\u00e9 consultatif sur le traitement de l\u2019information en mati\u00e8re de recherche dans le domaine de la sant\u00e9 (CCTIRS: Consultative committee for information management in health research\u2014No. 16.314) and the Comit\u00e9 de Protection des Personnes Ile-de-France V (CPP\u2014No. 18.12.28.38743 CAT2), in Germany by the Ethics Committee of the University Hospital of Cologne (No. 16-098) and in Spain by the Ethics Committee of the Instituto Catal\u00e1n de Oncolog\u00eda of Barcelona (No. PR111\/16). All recruited women provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}